Skip to content
OKUR·Nasdaq·US

OnKure

OnKure is a U.S.-listed biotechnology company focused on developing oncology therapeutics. It advances a pipeline of cancer drug candidates and may generate value through partnerships, licensing, and eventual product commercialization.

Thematic Position

OKUR

Relationship Groups

Suppliers1
Licensing1
Competitors4

Relationship details are part of the Pro plan.

Ended Relationships

1 ended relationship · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

tarifftrade restriction
US tariffs on China, Canada, Mexico imports and reciprocal global tariffs
SEC 10-KMar 12, 2026

The full regulatory passage is part of the Pro plan.

17 more · Regulatory and geopolitical insights are part of the Pro plan.